Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor pathway

J H McVey1

  • 1Haemostasis Research Group, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Bailliere'S Clinical Haematology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Blood coagulation, essential for vascular integrity, is initiated by tissue factor (TF) and factor VII (FVII). This complex interaction is regulated by inhibitors like tissue factor pathway inhibitor (TFPI) and antithrombin III (AT-III).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and characterization of a codon-optimized blood coagulation factor VIII.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.

Cell death discovery·2016
Same author

Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Fibrocytes mediate intimal hyperplasia post-vascular injury and are regulated by two tissue factor-dependent mechanisms.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Factor seven-activating protease: does it do what it says on the tin?

Journal of thrombosis and haemostasis : JTH·2012
Same author

In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression.

Gene therapy·2011
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Blood coagulation preserves vascular integrity following injury.
  • The coagulation cascade can be triggered by inflammation, leading to pathological fibrin deposition.
  • Tissue factor (TF) and factor VII (FVII) initiate the coagulation cascade upon blood exposure to TF.

Purpose of the Study:

  • To elucidate the molecular interactions in the TF-VIIa complex.
  • To understand the regulatory mechanisms controlling TF-VIIa activity.
  • To investigate the roles of TFPI and AT-III in coagulation regulation.

Main Methods:

  • Analysis of structure-function relationships of TF and FVII.
  • Investigating the formation of TF-VIIa complexes.

Related Experiment Videos

  • Studying the inhibitory mechanisms of TFPI and AT-III on TF-VIIa activity.

    • Main Results:

    • TF-VIIa complex formation involves rapid activation of FVII.
    • TF-VIIa activates FIX and FX, with FXa generation sustaining coagulation.
    • TFPI and AT-III inhibit TF-VIIa activity through distinct mechanisms.

    Conclusions:

    • Understanding the molecular structures of TF, FVII, and their complex is crucial.
    • TFPI is the primary regulator of TF-VIIa activity in hemostasis.
    • The potential auxiliary role of AT-III as a second regulator requires further investigation.